EMARSA 350 MG INJECTION
By Emarsa
Rx
1 Injection in a Vial

Composition
Daptomycin(350mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
September, 2025

liver
EMARSA 350 MG INJECTION is considered safe for use in patients with liver disease. The available data indicates that adjusting the dosage of EMARSA 350 MG INJECTION may not be necessary for patients with liver issues. However, if you have a pre-existing liver condition or a history of liver disease, it is important to inform your doctor before starting the medication. Your doctor may choose to adjust the dosage of EMARSA 350 MG INJECTION or recommend a different treatment option based on your specific liver condition. It is crucial to follow your doctor's guidance to ensure safe and effective use of this medication.

kidney
EMARSA 350 MG INJECTION should be used cautiously in patients with kidney issues. Dose adjustment may be necessary, so always consult your doctor before using this medication. Your doctor will evaluate and decide if the benefits outweigh the potential risks for your condition.

alcohol
While using EMARSA 350 MG INJECTION, it is advised to avoid consuming alcohol as it may worsen your condition. No harmful side effects are observed when alcohol is consumed with this injection.

driving
When taking EMARSA 350 MG INJECTION, be cautious about driving or using machinery due to potential dizziness and drowsiness caused by the medication. It is advisable to refrain from such activities to ensure safety.

pregnancy
EMARSA 350 MG INJECTION is generally safe during pregnancy based on animal studies. Limited human studies are available, so it should only be used if necessary. Inform your doctor if pregnant or planning a pregnancy before using.

breastfeeding
EMARSA 350 MG INJECTION is likely safe during breastfeeding based on limited human data showing minimal risk to the baby. It is advised to only use this medication while breastfeeding if essential, so consult your doctor beforehand.
Habit Forming | No |
Chemical Class | Lipopeptides |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Cell membrane active agent |
₹3950
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024